Goldman Sachs Group »

Vistagen Therapeutics Ord shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $842k 164k 5.14
2023-06-30 $107k 57k 1.87

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Vanguard Group
Commodore Capital
Citadel Advisors
Sphera Funds Management
Susquehanna International
BlackRock
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
Gts Securities

View all funds holding Vistagen Therapeutics Ord